Initiation of direct oral anticoagulation after reperfusion therapy in ischemic stroke in clinical practice: Results from Sits-International Stroke Registry
DOAC initiation time was not associated with any outcomes in AIS patients who received reperfusion therapy. Severe stroke symptoms at 24 h were associated with delayed DOAC initiation. The low incidence of safety outcomes and missing data in this study should lead to cautious interpretations of these results.
Authors
- Niaz Ahmed (ORCID: https://orcid.org/0000-0001-7970-0146)
- Tiago Moreira (ORCID: https://orcid.org/0000-0002-7613-5169)
- Michael V. Mazya (ORCID: https://orcid.org/0000-0002-0377-3506)
- Marius Matusevicius (ORCID: https://orcid.org/0000-0002-2868-127X)
- Maurizio Melis (ORCID: https://orcid.org/0000-0002-7761-804X)
- Aleksandras Vilionskis (ORCID: https://orcid.org/0000-0002-8055-3558)
- José Manuel Ferro (ORCID: https://orcid.org/0000-0002-2343-9097)
- J. Egido (ORCID: https://orcid.org/0000-0003-1698-9127)
- Marco Petruzzellis
- Diana Aguiar de Sousa (ORCID: https://orcid.org/0000-0002-6702-7924)
- Diana Melância (ORCID: https://orcid.org/0000-0003-0958-4834)
- Viiu‐Marika Rand (ORCID: https://orcid.org/0000-0001-8059-4192)
- Malin Säflund
- Janika Kõrv (ORCID: https://orcid.org/0000-0002-6074-0727)
- André Peeters (ORCID: https://orcid.org/0009-0002-6802-1898)
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- Karolinska University Hospital (SE)
- University of Lisbon (PT)
- Vilnius University (LT)
- Karolinska Institutet (SE)
- Hospital Clínico San Carlos (ES)
- North Estonia Medical Centre (EE)
- Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT)
- Unidade Local de Saúde de São José (PT)
- Azienda Ospedaliera G. Brotzu (IT)
- University of Bari Aldo Moro (IT)
- University of Tartu (EE)
Publication Details
- Journal
- European Stroke Journal
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1177/23969873251325978
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Boehringer Ingelheim
- Biogen
- Stryker
- Covidien
- Hjärt-Lungfonden
- Karolinska Institutet
- EVER Neuro Pharma
- Stockholm läns landsting
- Grupo Ferrer Internacional, S.A